Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Contributor

Brad Thompson, Ph.D.

Brad Thompson, Ph.D., is president and CEO of Oncolytics Biotech, a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics.

No contributions

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »